Ondansetron-induced QT prolongation among various age groups: a systematic review and meta-analysis
Abstract Background Ondansetron is a selective 5-hydroxytryptamine type 3 serotonin-receptor antagonist with antiemetic properties used inadvertently in the emergency department for controlling nausea. However, ondansetron is linked with a number of adverse effects, including prolongation of the QT...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-07-01
|
Series: | The Egyptian Heart Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43044-023-00385-y |